BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11241057)

  • 21. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
    Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
    Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
    [No Abstract]   [Full Text] [Related]  

  • 22. Investigation of the mechanisms of therapy-related hypoglycaemia in children with acute lymphoblastic leukaemia.
    Halonen P; Salo MK; Schmiegelow K; Mäkipernaa A
    Acta Paediatr; 2003; 92(1):37-42. PubMed ID: 12650297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intensification of chemotherapy in maintenance therapy and in periodic reinduction of remission in high-risk childhood ALL].
    Indiano JM; Echaniz I; Humayor J; Delgado A
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():94-8. PubMed ID: 3214047
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
    Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
    Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).
    Bell BA; Brockway GN; Shuster JJ; Erdmann G; Sterikoff S; Bostrom B; Camitta BM;
    Pediatr Blood Cancer; 2004 Aug; 43(2):105-9. PubMed ID: 15236274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection.
    El-Chennawi FA; Al-Tonbary YA; Mossad YM; Ahmed MA
    Hematology; 2008 Aug; 13(4):203-9. PubMed ID: 18796245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication errors on oral chemotherapy in children with acute lymphoblastic leukemia in a developing country.
    Oberoi S; Trehan A; Marwaha RK
    Pediatr Blood Cancer; 2014 Dec; 61(12):2218-22. PubMed ID: 25175850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia.
    Sandoval C; Jayabose S
    Pediatr Hematol Oncol; 2001; 18(3):217-20. PubMed ID: 11293291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?
    Te Poele EM; de Bont ES; Marike Boezen H; Revesz T; Bökkerink JP; Beishuizen A; Nijhuis IJ; Oude Nijhuis CS; Veerman AJ; Kamps WA
    Eur J Cancer; 2007 Nov; 43(17):2532-6. PubMed ID: 17702568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
    Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis B in children with leukemia and lymphoma].
    Jackowska T; Kalinowska B; Rokicka-Milewska R; Derulska D; Sopyło B; Makowska K
    Wiad Lek; 1990 Jul; 43(13):645-51. PubMed ID: 2256326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
    Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
    Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Erwinia asparaginase antibodies during treatment of childhood acute lymphoblastic leukemia and their relationship to outcome: a case-control study.
    Klug Albertsen B; Schmiegelow K; Schrøder H; Carlsen NT; Rosthøj S; Avramis VI; Jakobsen P
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):117-20. PubMed ID: 12172975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients' Adherence in the Maintenance Therapy of Children and Adolescents with Acute Lymphoblastic Leukemia.
    Kremeike K; Juergens C; Alz H; Reinhardt D
    Klin Padiatr; 2015 Nov; 227(6-7):329-34. PubMed ID: 26457956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Infectious complications of the treatment of acute lymphoblastic leukemia in children].
    Rubie H; Assouline C; Prere MF; Dutour A; Lemozy J; Mouls JL; Gayet-Mengelle C; Robert A
    Pediatrie; 1990; 45(5):333-8. PubMed ID: 2165247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia.
    Cole PD; Beckwith KA; Vijayanathan V; Roychowdhury S; Smith AK; Kamen BA
    Pediatr Neurol; 2009 Jan; 40(1):34-41. PubMed ID: 19068252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of 6-thioguanine nucleotides into DNA during maintenance therapy of childhood acute lymphoblastic leukemia-the influence of thiopurine methyltransferase genotypes.
    Ebbesen MS; Nersting J; Jacobsen JH; Frandsen TL; Vettenranta K; Abramsson J; Wesenberg F; Schmiegelow K
    J Clin Pharmacol; 2013 Jun; 53(6):670-4. PubMed ID: 23585236
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebrospinal fluid insulin-like growth factor (IGF-1) and insulin-like growth factor binding protein (IGFBP-2) in children with acute lymphoblastic leukemia.
    Riikonen R; Vettenranta K; Riikonen P; Turpeinen U; Saarinen-Pihkala UM
    Pediatr Blood Cancer; 2004 Aug; 43(2):110-4. PubMed ID: 15236275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.